Tilelizumab (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tilelizumab (investigational), covering 2023-02-16 to 2023-02-16. Get the full timeline:
Most recent: Clinical Trial Update: TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC [Phase 2]